companies that make glp-1 drugs Compound versions of for weight loss halted by FDA WLP-1: Oral GLP-1 Support
Description
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents

10.1007/s00125-012-2653-7 158 StineZ

Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: A report of the American college of cardiology solution set oversight committee
Clinical trials may differ in patient population, baseline weight and BMI, diabetes status, medication dose, treatment duration, nutrition and lifestyle support, dropout rates, side-effect profiles, study design, and whether the data are published, peer-reviewed, or topline results
Patience during the adaptation window is one of the most important factors in long-term treatment success and comfort

Front Immunol 2016